Abstract
Abstract Ionic liquids (ILs) recently draw attention for addressing unmet needs in biomedicines. By converting solids into liquids, ILs are emerging as novel platforms to overcome some critical drawbacks associated with the application of solid or crystalline active pharmaceutical ingredients (APIs). ILs have shown promise in liquidizing or solubilizing APIs, or as green solvents, novel permeation enhancers or active ingredients, alone or synergistically with APIs. Meanwhile, challenges turn up in company with the deepening understanding of ILs as drug delivery carrier systems. This perspective aims to provide a sketchy overview on the status quo with specific attention paid to new problems arising from the utilization of ILs-based technologies in drug delivery.
Similar content being viewed by others
Referrences
Agatemor C, Ibsen KN, Tanner EEL, Mitragotri S. Ionic liquids for addressing unmet needs in healthcare. Bioeng Transl Med. 2018;3(1):7–25.
Gomes JM, Silva SS, Reis RL. Biocompatible ionic liquids: fundamental behaviours and applications. Chem Soc Rev. 2019;48(15):4317–35.
Curreri AM, Mitragotri S, Tanner EEL. Recent advances in ionic liquids in biomedicine. Adv Sci. 2021;8(17):e2004819.
Ali MK, Moshikur RM, Goto M, Moniruzzaman M. Recent developments in ionic liquid-assisted topical and transdermal drug delivery. Pharm Res. 2022. https://doi.org/10.1007/s11095-022-03322-x.
Qader IB, Prasad K. Recent developments on ionic liquids and deep eutectic solvents for drug delivery applications. Pharm Res. 2022. https://doi.org/10.1007/s11095-022-03315-w.
Jiang L, Sun Y, Lu A, Wang X, Shi Y. Ionic liquids: promising approach for oral drug delivery. Pharm Res. 2022. https://doi.org/10.1007/s11095-022-03260-8.
Dib N, Silber JJ, Correa NM, Falcone RD. Amphiphilic ionic liquids capable to formulate organized systems in an aqueous solution, designed by a combination of traditional surfactants and commercial drugs. Pharm Res. 2022. https://doi.org/10.1007/s11095-022-03342-7.
Huang W, Wu X, Qi J, Zhu Q, Wu W, Lu Y, Chen Z. Ionic liquids: green and tailor-made solvents in drug delivery. Drug Discov Today. 2020;25(5):901–8.
Gomes A, Aguiar L, Ferraz R, Teixeira C, Gomes P. The emerging role of ionic liquid-based approaches for enhanced skin permeation of bioactive molecules: a snapshot of the past couple of years. Int J Mol Sci. 2021;22(21):11991.
Egorova KS, Gordeev EG, Ananikov VP. Biological activity of ionic liquids and their application in pharmaceutics and medicine. Chem Rev. 2017;117(10):7132–89.
Wu X, Zhu Q, Chen Z, Wu W, Lu Y, Qi J. Ionic liquids as a useful tool for tailoring active pharmaceutical ingredients. J Control Release. 2021;338:268–83.
Shamshina JL, Barber PS, Rogers RD. Ionic liquids in drug delivery. Expert Opin Drug Deliv. 2013;10(10):1367–81.
Huang W, Fang Z, Zheng X, Qi J, Wu W, Lu Y. Green and controllable fabrication of nanocrystals from ionic liquids. Chin Chem Lett. 2022;33(8):4079–83.
Balk A, Holzgrabe U, Meinel L. ‘Pro et contra’ ionic liquid drugs - Challenges and opportunities for pharmaceutical translation. Eur J Pharm Biopharm. 2015;94:291–304.
Shi Y, Zhao Z, Gao Y, Pan DC, Salinas AK, Tanner EEL, Guo J, Mitragotri S. Oral delivery of sorafenib through spontaneous formation of ionic liquid nanocomplexes. J Control Release. 2020;322:602–9.
Ali MK, Moshikur RM, Wakabayashi R, Moniruzzaman M, Goto M. Biocompatible ionic liquid-mediated micelles for enhanced transdermal delivery of paclitaxel. ACS Appl Mater Interfaces. 2021;13(17):19745–55.
Zheng X, Fang Z, Huang W, Qi J, Dong X, Zhao W, Wu W, Lu Y. Ionic co-aggregates (ICAs) based oral drug delivery: solubilization and permeability improvement. Acta Pharm Sin B. 2022. https://doi.org/10.1016/j.apsb.2022.04.011.
Stoimenovski J, MacFarlane DR, Bica K, Rogers RD. Crystalline vs. ionic liquid salt forms of active pharmaceutical ingredients: a position paper. Pharm Res. 2010;27(4):521–6.
Flieger J, Flieger M. Ionic liquids toxicity-benefits and threats. Int J Mol Sci. 2020;21(17):6267.
Tsolaki E, Stocker MW, Healy AM, Ferguson S. Formulation of ionic liquid APIs via spray drying processes to enable conversion into single and two-phase solid forms. Int J Pharm. 2021;603:120669.
Funding
This work is financially supported by Shanghai Municipality Commission of Science and Technology (19XD1400300; 21430760800).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no competing financial interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Lu, Y., Qi, J. & Wu, W. Ionic Liquids-Based Drug Delivery: a Perspective. Pharm Res 39, 2329–2334 (2022). https://doi.org/10.1007/s11095-022-03362-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-022-03362-3